FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993308231> ?p ?o ?g. }

• W1993308231 endingPage "79" @default.
• W1993308231 startingPage "70" @default.
• W1993308231 abstract "Type 2 diabetes mellitus (T2DM) is currently considered a worldwide epidemic and finding effective therapeutic strategies against this disease is highly important. A deoxynojirimycin–polysaccharide mixture (DPM) has previously been shown to exert hypoglycemic effects on alloxan- or streptozotocin (STZ)-induced diabetic mice. The purpose of the present study was to evaluate the therapeutic effects and underlying mechanism(s) of DPM on T2DM induced by high fat diet following low-dose STZ treatment in mice. After daily oral treatment of diabetic mice with DPM (150 mg/kg b.w.) for 90 d, significant decline in blood glucose, pyruvate, triglyceride (TG), aspartate transaminase (AST), alanine transaminase (ALT), creatinine (Cr), lipid peroxide (LPO) and malondialdehyde (MDA) levels as well as evident increases in high density lipoprotein (HDL-c) and hepatic glycogen concentrations were observed. In the first stage, in which DPM was administered for 60 d, blood insulin levels did not undergo significant change but a significant decrease in the HOMA-IR index was detected. By contrast, the HOMA-IR index increased significantly in T2MD controls. In the second stage, in which DPM treatment was continued for another 30 d, insulin levels significantly increased in DPM-treated mice in comparison with T2DM controls. These results indicate that insulin resistance in the pre-diabetic period and the dysfunction of pancreatic β-cells are ameliorated by DPM treatment. DPM also down-regulated protein levels of insulin receptor (IR) and gluconeogenic enzymes (pyruvate carboxylase, fructose-1, 6-bisphosphatase, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase) in peripheral tissues (liver and/or muscle), but enhanced the expressions of insulin in pancreas, lipoprotein lipase (LPL) and glycolysis enzymes (glucokinase, phosphofructokinase, private kinase and pyruvate decarboxylase E1) in the liver. Furthermore, deoxynojirimycin (DNJ) and polysaccharide (P) were found to increase proliferation of hepatic LO-2 cells and scavenging of radicals in vitro. These results support the results of our biochemical analyses and underscore possible mechanisms underlying the protective effects of DPM on STZ-induced damage to the pancreas and the liver. Taken together, our findings suggest that DPM may be developed as an antihyperglycemic agent for the treatment of diabetes mellitus." @default.
• W1993308231 created "2016-06-24" @default.
• W1993308231 creator A5010426520 @default.
• W1993308231 creator A5033243530 @default.
• W1993308231 creator A5034673863 @default.
• W1993308231 creator A5048018098 @default.
• W1993308231 creator A5061026909 @default.
• W1993308231 date "2015-01-01" @default.
• W1993308231 modified "2023-09-30" @default.
• W1993308231 title "Hypoglycemic effect of deoxynojirimycin–polysaccharide on high fat diet and streptozotocin-induced diabetic mice via regulation of hepatic glucose metabolism" @default.
• W1993308231 cites W1967206579 @default.
• W1993308231 cites W1970226246 @default.
• W1993308231 cites W1971528399 @default.
• W1993308231 cites W1972388850 @default.
• W1993308231 cites W1983469557 @default.
• W1993308231 cites W1994787654 @default.
• W1993308231 cites W1995303815 @default.
• W1993308231 cites W1996852491 @default.
• W1993308231 cites W2000047954 @default.
• W1993308231 cites W2004922828 @default.
• W1993308231 cites W2007680549 @default.
• W1993308231 cites W2008111811 @default.
• W1993308231 cites W2014717092 @default.
• W1993308231 cites W2018266513 @default.
• W1993308231 cites W2021010709 @default.
• W1993308231 cites W2022164197 @default.
• W1993308231 cites W2023440211 @default.
• W1993308231 cites W2027225244 @default.
• W1993308231 cites W2033395930 @default.
• W1993308231 cites W2033501232 @default.
• W1993308231 cites W2039762060 @default.
• W1993308231 cites W2040864865 @default.
• W1993308231 cites W2046019554 @default.
• W1993308231 cites W2048767788 @default.
• W1993308231 cites W2049848817 @default.
• W1993308231 cites W2056224034 @default.
• W1993308231 cites W2063848448 @default.
• W1993308231 cites W2069482173 @default.
• W1993308231 cites W2074652188 @default.
• W1993308231 cites W2076244017 @default.
• W1993308231 cites W2076297693 @default.
• W1993308231 cites W2078085246 @default.
• W1993308231 cites W2078841469 @default.
• W1993308231 cites W2083031489 @default.
• W1993308231 cites W2088927196 @default.
• W1993308231 cites W2092340120 @default.
• W1993308231 cites W2093623924 @default.
• W1993308231 cites W2157899600 @default.
• W1993308231 cites W2160234571 @default.
• W1993308231 cites W2168323414 @default.
• W1993308231 cites W2170460248 @default.
• W1993308231 doi "https://doi.org/10.1016/j.cbi.2014.11.003" @default.
• W1993308231 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25446853" @default.
• W1993308231 hasPublicationYear "2015" @default.
• W1993308231 type Work @default.
• W1993308231 sameAs 1993308231 @default.
• W1993308231 citedByCount "39" @default.
• W1993308231 countsByYear W19933082312015 @default.
• W1993308231 countsByYear W19933082312016 @default.
• W1993308231 countsByYear W19933082312017 @default.
• W1993308231 countsByYear W19933082312018 @default.
• W1993308231 countsByYear W19933082312019 @default.
• W1993308231 countsByYear W19933082312020 @default.
• W1993308231 countsByYear W19933082312021 @default.
• W1993308231 countsByYear W19933082312022 @default.
• W1993308231 countsByYear W19933082312023 @default.
• W1993308231 crossrefType "journal-article" @default.
• W1993308231 hasAuthorship W1993308231A5010426520 @default.
• W1993308231 hasAuthorship W1993308231A5033243530 @default.
• W1993308231 hasAuthorship W1993308231A5034673863 @default.
• W1993308231 hasAuthorship W1993308231A5048018098 @default.
• W1993308231 hasAuthorship W1993308231A5061026909 @default.
• W1993308231 hasConcept C126322002 @default.
• W1993308231 hasConcept C134018914 @default.
• W1993308231 hasConcept C160160445 @default.
• W1993308231 hasConcept C17093226 @default.
• W1993308231 hasConcept C181199279 @default.
• W1993308231 hasConcept C185592680 @default.
• W1993308231 hasConcept C2777391703 @default.
• W1993308231 hasConcept C2777499176 @default.
• W1993308231 hasConcept C2778163477 @default.
• W1993308231 hasConcept C2778606649 @default.
• W1993308231 hasConcept C2778772119 @default.
• W1993308231 hasConcept C2778913445 @default.
• W1993308231 hasConcept C2779134260 @default.
• W1993308231 hasConcept C2779280383 @default.
• W1993308231 hasConcept C2779306644 @default.
• W1993308231 hasConcept C2779679107 @default.
• W1993308231 hasConcept C55493867 @default.
• W1993308231 hasConcept C555293320 @default.
• W1993308231 hasConcept C71924100 @default.
• W1993308231 hasConceptScore W1993308231C126322002 @default.
• W1993308231 hasConceptScore W1993308231C134018914 @default.
• W1993308231 hasConceptScore W1993308231C160160445 @default.
• W1993308231 hasConceptScore W1993308231C17093226 @default.
• W1993308231 hasConceptScore W1993308231C181199279 @default.
• W1993308231 hasConceptScore W1993308231C185592680 @default.
• W1993308231 hasConceptScore W1993308231C2777391703 @default.

• next